Cargando…

Effects of roniciclib in preclinical models of anaplastic thyroid cancer

Many human cancers have altered cyclin-dependent kinase activity. Inhibition of cyclin-dependent kinases may arrest cell cycle progression and represents an important strategy in the treatment of malignancies. We evaluated the therapeutic effects of roniciclib, a cyclin-dependent kinase inhibitor, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shu-Fu, Lin, Jen-Der, Hsueh, Chuen, Chou, Ting-Chao, Wong, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620230/ https://www.ncbi.nlm.nih.gov/pubmed/28978090 http://dx.doi.org/10.18632/oncotarget.19092

Ejemplares similares

Activity of roniciclib in medullary thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2018)

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
por: Lin, Shu-Fu, et al.
Publicado: (2017)

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Therapeutic inhibition of polo‐like kinases in anaplastic thyroid cancer
por: Lin, Shu‐Fu, et al.
Publicado: (2021)

Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
por: Lin, Shu-Fu, et al.
Publicado: (2012)

Soft tissue invasion of papillary thyroid carcinoma
por: Lin, Jen-Der, et al.
Publicado: (2016)

Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020)

Utility of a Histone Deacetylase Inhibitor (PXD101) for Thyroid Cancer Treatment
por: Lin, Shu-Fu, et al.
Publicado: (2013)

Prognosis of Multifocal Papillary Thyroid Carcinoma
por: Kuo, Sheng-Fong, et al.
Publicado: (2013)

Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis
por: Lin, Jen-Der, et al.
Publicado: (2017)

Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies
por: Bahleda, Rastislav, et al.
Publicado: (2017)

Anaplastic thyroid cancer: outcomes of trimodal therapy
por: Houlihan, Orla A., et al.
Publicado: (2021)

Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis
por: Lin, Jen-Der, et al.
Publicado: (2015)

Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
por: Enomoto, Keisuke, et al.
Publicado: (2021)

Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer
por: Liou, Miaw-Jene, et al.
Publicado: (2016)

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
por: Sewell, Will, et al.
Publicado: (2013)

Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV
por: Hsieh, Sheng-Hwu, et al.
Publicado: (2012)

Gene master regulators of papillary and anaplastic thyroid cancers
por: Iacobas, Dumitru A., et al.
Publicado: (2017)

FOXD3 regulates anaplastic thyroid cancer progression
por: Yin, Huabin, et al.
Publicado: (2017)

SPC24 is critical for anaplastic thyroid cancer progression
por: Yin, Huabin, et al.
Publicado: (2017)

Disease-Specific Mortality and Secondary Primary Cancer in Well-Differentiated Thyroid Cancer with Type 2 Diabetes Mellitus
por: Chen, Szu-Tah, et al.
Publicado: (2013)

Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery
por: Wu, Chia-Chun, et al.
Publicado: (2018)

MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer
por: Garcia, Cyril, et al.
Publicado: (2019)

Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study
por: Lu, Yu-Ling, et al.
Publicado: (2021)

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis
por: Liu, Feng‐Hsuan, et al.
Publicado: (2015)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
por: Adam, Pia, et al.
Publicado: (2021)

Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer
por: Lu, Yu-Ling, et al.
Publicado: (2021)

Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer
por: Liu, Fu-Chao, et al.
Publicado: (2017)

The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
por: Mika, Justyna, et al.
Publicado: (2020)

Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer
por: De Andrade, James P., et al.
Publicado: (2017)

Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
por: Zhang, Lisa, et al.
Publicado: (2016)

Risk Factors for Anaplastic Thyroid Cancer
por: Zivaljevic, V., et al.
Publicado: (2014)

Treatment Outcomes in Anaplastic Thyroid Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2019)

Anaplastic Cancer of the Thyroid: The Viper in the Pit
por: Seshadri, Krishna G.
Publicado: (2019)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Anaplastic Thyroid Cancer Successfully Treated With Radiation and Immunotherapy: A Case Report
por: Yang, Shuen-Ru, et al.
Publicado: (2021)

UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer
por: Wang, Bi-Cheng, et al.
Publicado: (2016)

Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo
por: Xiong, Le, et al.
Publicado: (2021)

The Role of Tracheostomy in Anaplastic Thyroid Carcinoma
por: Xu, Jia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nj8vui7udimk0ls3j7lb80p2cj